RAYMOND W COHEN Insider Trading $AXNX Axonics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND W COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND W COHEN. RAYMOND W COHEN is Director in BIOLIFE SOLUTIONS INC ($BLFS) and CEO in CARDIAC SCIENCE INC ($DFIB) and Chairman and CEO in CARDIAC SCIENCE INC ($DFIB) and Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Chief Executive Officer in Axonics Modulation Technologies, Inc. ($AXNX).
RAYMOND W COHEN in Axonics, Inc.
Trading Symbol: AXNXIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of RAYMOND W COHEN: Chief Executive Officer
Holdings: 284,607 shares
Latest Transaction: Jun 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RAYMOND W COHEN in Axonics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXNX, BLFS, DFIB, SPPI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 60.00 | 33,333 | 1,999,980 | 284,607 | 317.9 K to 284.6 K (-10.48 %) |
May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.81 | 2,770 | 151,824 | 350,773 | 353.5 K to 350.8 K (-0.78 %) |
May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 54.13 | 17,954 | 971,798 | 353,543 | 371.5 K to 353.5 K (-4.83 %) |
May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 52.98 | 13,109 | 694,536 | 371,497 | 384.6 K to 371.5 K (-3.41 %) |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,500 | 0 | 42,500 | |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 52.12 | 952 | 49,616 | 456,096 | 457 K to 456.1 K (-0.21 %) |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 51.36 | 12,675 | 651,045 | 457,048 | 469.7 K to 457 K (-2.70 %) |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 33,334 | 0 | 469,723 | 436.4 K to 469.7 K (+7.64 %) |
Feb 02 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Grant | A | 0.00 | 20,000 | 0 | 436,389 | 416.4 K to 436.4 K (+4.80 %) |
Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 27,173 | 0 | 0 | |
Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 53.58 | 7,842 | 420,148 | 416,389 | 424.2 K to 416.4 K (-1.85 %) |
Jan 27 2021 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 27,173 | 0 | 424,231 | 397.1 K to 424.2 K (+6.84 %) |
Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.78 | 11,033 | 471,948 | 397,058 | 408.1 K to 397.1 K (-2.70 %) |
Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.05 | 8,808 | 370,406 | 408,091 | 416.9 K to 408.1 K (-2.11 %) |
Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.95 | 5,159 | 211,282 | 416,899 | 422.1 K to 416.9 K (-1.22 %) |
Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 42.75 | 3,367 | 143,924 | 422,058 | 425.4 K to 422.1 K (-0.79 %) |
Aug 11 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.82 | 16,633 | 695,659 | 425,425 | 442.1 K to 425.4 K (-3.76 %) |
Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.65 | 25,000 | 991,268 | 442,058 | 467.1 K to 442.1 K (-5.35 %) |
Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.94 | 900 | 35,943 | 467,058 | 468 K to 467.1 K (-0.19 %) |
Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 39.61 | 15,472 | 612,804 | 467,958 | 483.4 K to 468 K (-3.20 %) |
Jul 17 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 38.55 | 8,628 | 332,579 | 483,430 | 492.1 K to 483.4 K (-1.75 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 36.49 | 25,000 | 912,273 | 492,058 | 517.1 K to 492.1 K (-4.84 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.10 | 200 | 8,220 | 517,058 | 517.3 K to 517.1 K (-0.04 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.34 | 24,800 | 1,000,541 | 517,258 | 542.1 K to 517.3 K (-4.58 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 36.49 | 25,000 | 912,273 | 492,058 | 517.1 K to 492.1 K (-4.84 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 41.10 | 200 | 8,220 | 517,058 | 517.3 K to 517.1 K (-0.04 %) |
Jul 15 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 40.34 | 24,800 | 1,000,541 | 517,258 | 542.1 K to 517.3 K (-4.58 %) |
Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 41,224 | 67,195 | 106,776 | |
Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 21.48 | 6,955 | 149,390 | 542,058 | 549 K to 542.1 K (-1.27 %) |
Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 20.87 | 34,269 | 715,249 | 549,013 | 583.3 K to 549 K (-5.88 %) |
Mar 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 41,224 | 67,195 | 583,282 | 542.1 K to 583.3 K (+7.61 %) |
Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 10,000 | 16,300 | 148,000 | |
Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 33.21 | 10,000 | 332,065 | 542,058 | 552.1 K to 542.1 K (-1.81 %) |
Feb 18 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 10,000 | 16,300 | 552,058 | 542.1 K to 552.1 K (+1.84 %) |
Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 16,667 | 0 | 625,058 | 608.4 K to 625.1 K (+2.74 %) |
Feb 03 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 0.00 | 16,667 | 0 | 625,058 | 608.4 K to 625.1 K (+2.74 %) |
Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | M | 1.63 | 10,000 | 16,300 | 158,000 | |
Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 31.98 | 10,000 | 319,800 | 608,391 | 618.4 K to 608.4 K (-1.62 %) |
Jan 16 2020 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | M | 1.63 | 10,000 | 16,300 | 618,391 | 608.4 K to 618.4 K (+1.64 %) |
Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 25.82 | 78,125 | 2,017,188 | 78,125 | |
Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 27,173 | 0 | 27,173 | |
Dec 16 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 27,173 | 0 | 27,173 | |
Nov 21 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Sell | S | 20.74 | 75,000 | 1,555,125 | 608,391 | 683.4 K to 608.4 K (-10.97 %) |
Aug 06 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | P | 30.41 | 3,500 | 106,439 | 683,391 | 679.9 K to 683.4 K (+0.51 %) |
Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Feb 04 2019 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | A | 14.19 | 222,222 | 3,153,330 | 222,222 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Option Exercise | C | 0.00 | 7,300 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | COHEN RAYMOND W | Chief Executive Off ... | Buy | C | 0.00 | 8,760 | 0 | 688,651 | 679.9 K to 688.7 K (+1.29 %) |
Page: 1